rethinkPeptides Search
Menu
Research citation

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Lancet (London, England), 386(9999), 1147-55

Citation

Leder, Benjamin Z; Tsai, Joy N; Uihlein, Alexander V; Wallace, Paul M; Lee, Hang; Neer, Robert M; Burnett-Bowie, Sherri-Ann M. (2015). Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.. Lancet (London, England), 386(9999), 1147-55. https://doi.org/10.1016/S0140-6736(15)61120-5